An international clinical trial to evaluate new therapies to improve survival of children with relapsed acute lymphoblastic leukaemia [ 2012 - ]

Research Grant

Researchers: A/Pr Tamas Revesz (Principal investigator) ,  A/Pr Rosemary Sutton ,  Dr Arend von Stackelberg ,  Prof Richard Lock ,  Prof Vaskar Saha

Brief description Children who relapse with childhood leukaemia have only a 50% chance of being alive after 5 years. We will participate in a new international trial involving most European and all Australian and New Zealand childhood oncology centres, to test the effectiveness of promising new treatments and to perform biological studies which should enable doctors in future to pick the best treatment for each of these patients.

Funding Amount $1,567,500.00

Funding Scheme Project Grants

Notes Standard Project Grant